nodes	percent_of_prediction	percent_of_DWPC	metapath
Estriol—ESR1—ovarian cancer	0.345	0.702	CbGaD
Estriol—SLCO1A2—Chlorambucil—ovarian cancer	0.19	0.654	CbGbCtD
Estriol—ABCB1—ovarian cancer	0.146	0.298	CbGaD
Estriol—ABCB1—Topotecan—ovarian cancer	0.0356	0.123	CbGbCtD
Estriol—ABCB1—Vinorelbine—ovarian cancer	0.0251	0.0863	CbGbCtD
Estriol—ABCB1—Paclitaxel—ovarian cancer	0.0176	0.0606	CbGbCtD
Estriol—ABCB1—Docetaxel—ovarian cancer	0.0127	0.0438	CbGbCtD
Estriol—ESR2—ovarian follicle—ovarian cancer	0.0124	0.194	CbGeAlD
Estriol—ABCB1—Doxorubicin—ovarian cancer	0.00949	0.0327	CbGbCtD
Estriol—ESR1—ovarian follicle—ovarian cancer	0.00847	0.133	CbGeAlD
Estriol—ESR2—oviduct—ovarian cancer	0.00543	0.0852	CbGeAlD
Estriol—ESR1—oviduct—ovarian cancer	0.00372	0.0584	CbGeAlD
Estriol—ESR2—epithelium—ovarian cancer	0.00136	0.0214	CbGeAlD
Estriol—ESR2—uterine cervix—ovarian cancer	0.00135	0.0212	CbGeAlD
Estriol—ESR2—endometrium—ovarian cancer	0.00122	0.0192	CbGeAlD
Estriol—ESR1—myometrium—ovarian cancer	0.00119	0.0187	CbGeAlD
Estriol—SHBG—endometrium—ovarian cancer	0.00119	0.0187	CbGeAlD
Estriol—ESR1—embryo—ovarian cancer	0.00115	0.018	CbGeAlD
Estriol—ESR2—gonad—ovarian cancer	0.00113	0.0178	CbGeAlD
Estriol—ESR2—uterus—ovarian cancer	0.00113	0.0177	CbGeAlD
Estriol—SHBG—gonad—ovarian cancer	0.0011	0.0173	CbGeAlD
Estriol—SHBG—uterus—ovarian cancer	0.0011	0.0172	CbGeAlD
Estriol—ESR2—female reproductive system—ovarian cancer	0.00101	0.0159	CbGeAlD
Estriol—SHBG—female reproductive system—ovarian cancer	0.000985	0.0155	CbGeAlD
Estriol—ESR1—epithelium—ovarian cancer	0.000934	0.0147	CbGeAlD
Estriol—SHBG—bone marrow—ovarian cancer	0.00093	0.0146	CbGeAlD
Estriol—ESR1—uterine cervix—ovarian cancer	0.000926	0.0145	CbGeAlD
Estriol—ESR2—female gonad—ovarian cancer	0.000922	0.0145	CbGeAlD
Estriol—ESR2—vagina—ovarian cancer	0.000917	0.0144	CbGeAlD
Estriol—SHBG—female gonad—ovarian cancer	0.000896	0.0141	CbGeAlD
Estriol—SHBG—vagina—ovarian cancer	0.000891	0.014	CbGeAlD
Estriol—ESR1—decidua—ovarian cancer	0.000883	0.0138	CbGeAlD
Estriol—ESR1—endometrium—ovarian cancer	0.000838	0.0131	CbGeAlD
Estriol—ESR2—testis—ovarian cancer	0.000818	0.0128	CbGeAlD
Estriol—SHBG—testis—ovarian cancer	0.000795	0.0125	CbGeAlD
Estriol—Quinestrol—ESR1—ovarian cancer	0.000778	0.175	CrCbGaD
Estriol—ESR1—gonad—ovarian cancer	0.000777	0.0122	CbGeAlD
Estriol—ESR1—uterus—ovarian cancer	0.000772	0.0121	CbGeAlD
Estriol—ESR1—female reproductive system—ovarian cancer	0.000694	0.0109	CbGeAlD
Estriol—SLCO1A2—testis—ovarian cancer	0.00066	0.0104	CbGeAlD
Estriol—ESR1—female gonad—ovarian cancer	0.000632	0.00991	CbGeAlD
Estriol—ESR1—vagina—ovarian cancer	0.000628	0.00985	CbGeAlD
Estriol—ESR2—lymph node—ovarian cancer	0.000593	0.0093	CbGeAlD
Estriol—Mestranol—ESR1—ovarian cancer	0.000589	0.133	CrCbGaD
Estriol—ESR1—testis—ovarian cancer	0.00056	0.00879	CbGeAlD
Estriol—Estramustine—ESR1—ovarian cancer	0.000478	0.108	CrCbGaD
Estriol—ABCB1—myometrium—ovarian cancer	0.00047	0.00738	CbGeAlD
Estriol—ABCB1—embryo—ovarian cancer	0.000452	0.00709	CbGeAlD
Estriol—ESR1—lymph node—ovarian cancer	0.000406	0.00637	CbGeAlD
Estriol—Estropipate—ESR1—ovarian cancer	0.000393	0.0885	CrCbGaD
Estriol—ABCB1—epithelium—ovarian cancer	0.000369	0.00579	CbGeAlD
Estriol—ABCB1—uterine cervix—ovarian cancer	0.000366	0.00574	CbGeAlD
Estriol—Estrone—CYP1B1—ovarian cancer	0.000362	0.0816	CrCbGaD
Estriol—ABCB1—decidua—ovarian cancer	0.000349	0.00547	CbGeAlD
Estriol—ABCB1—endometrium—ovarian cancer	0.000331	0.00519	CbGeAlD
Estriol—ABCB1—gonad—ovarian cancer	0.000307	0.00482	CbGeAlD
Estriol—ABCB1—uterus—ovarian cancer	0.000305	0.00478	CbGeAlD
Estriol—Ethinyl Estradiol—ESR1—ovarian cancer	0.000281	0.0633	CrCbGaD
Estriol—Estradiol—CYP1B1—ovarian cancer	0.000275	0.0618	CrCbGaD
Estriol—ABCB1—female reproductive system—ovarian cancer	0.000274	0.0043	CbGeAlD
Estriol—ABCB1—bone marrow—ovarian cancer	0.000259	0.00406	CbGeAlD
Estriol—ABCB1—female gonad—ovarian cancer	0.000249	0.00391	CbGeAlD
Estriol—ABCB1—vagina—ovarian cancer	0.000248	0.00389	CbGeAlD
Estriol—Conjugated Estrogens—ESR1—ovarian cancer	0.000245	0.0553	CrCbGaD
Estriol—Estrone—ESR1—ovarian cancer	0.000245	0.0551	CrCbGaD
Estriol—ABCB1—testis—ovarian cancer	0.000221	0.00347	CbGeAlD
Estriol—Anaphylactic shock—Vinorelbine—ovarian cancer	0.000214	0.0022	CcSEcCtD
Estriol—Pain—Topotecan—ovarian cancer	0.000214	0.0022	CcSEcCtD
Estriol—Hepatobiliary disease—Paclitaxel—ovarian cancer	0.000214	0.0022	CcSEcCtD
Estriol—Vaginal inflammation—Doxorubicin—ovarian cancer	0.000214	0.0022	CcSEcCtD
Estriol—Pulmonary embolism—Doxorubicin—ovarian cancer	0.000214	0.0022	CcSEcCtD
Estriol—Infection—Vinorelbine—ovarian cancer	0.000213	0.00219	CcSEcCtD
Estriol—Cramps of lower extremities—Epirubicin—ovarian cancer	0.000212	0.00218	CcSEcCtD
Estriol—Gastrointestinal disorder—Melphalan—ovarian cancer	0.000212	0.00218	CcSEcCtD
Estriol—Nervous system disorder—Vinorelbine—ovarian cancer	0.00021	0.00216	CcSEcCtD
Estriol—Pain—Melphalan—ovarian cancer	0.00021	0.00216	CcSEcCtD
Estriol—Neoplasm—Epirubicin—ovarian cancer	0.000209	0.00215	CcSEcCtD
Estriol—Skin disorder—Vinorelbine—ovarian cancer	0.000208	0.00214	CcSEcCtD
Estriol—Hypersensitivity—Chlorambucil—ovarian cancer	0.000207	0.00213	CcSEcCtD
Estriol—Gastrointestinal pain—Topotecan—ovarian cancer	0.000205	0.0021	CcSEcCtD
Estriol—Estramustine—ABCB1—ovarian cancer	0.000203	0.0457	CrCbGaD
Estriol—Fluid retention—Doxorubicin—ovarian cancer	0.000203	0.00208	CcSEcCtD
Estriol—Vaginal infection—Doxorubicin—ovarian cancer	0.000202	0.00207	CcSEcCtD
Estriol—Abnormal vision—Epirubicin—ovarian cancer	0.000202	0.00207	CcSEcCtD
Estriol—Oedema peripheral—Paclitaxel—ovarian cancer	0.0002	0.00205	CcSEcCtD
Estriol—Connective tissue disorder—Paclitaxel—ovarian cancer	0.0002	0.00205	CcSEcCtD
Estriol—Pruritus—Chlorambucil—ovarian cancer	0.000199	0.00205	CcSEcCtD
Estriol—Urticaria—Topotecan—ovarian cancer	0.000199	0.00204	CcSEcCtD
Estriol—Abdominal pain—Topotecan—ovarian cancer	0.000198	0.00203	CcSEcCtD
Estriol—Cramps of lower extremities—Doxorubicin—ovarian cancer	0.000196	0.00202	CcSEcCtD
Estriol—Weight increased—Docetaxel—ovarian cancer	0.000196	0.00201	CcSEcCtD
Estriol—Visual impairment—Paclitaxel—ovarian cancer	0.000196	0.00201	CcSEcCtD
Estriol—Urticaria—Melphalan—ovarian cancer	0.000195	0.002	CcSEcCtD
Estriol—Weight decreased—Docetaxel—ovarian cancer	0.000195	0.002	CcSEcCtD
Estriol—Thrombophlebitis—Epirubicin—ovarian cancer	0.000194	0.00199	CcSEcCtD
Estriol—Neoplasm—Doxorubicin—ovarian cancer	0.000193	0.00199	CcSEcCtD
Estriol—Diarrhoea—Chlorambucil—ovarian cancer	0.000193	0.00198	CcSEcCtD
Estriol—Erythema multiforme—Paclitaxel—ovarian cancer	0.000192	0.00197	CcSEcCtD
Estriol—Infestation—Docetaxel—ovarian cancer	0.000192	0.00197	CcSEcCtD
Estriol—Infestation NOS—Docetaxel—ovarian cancer	0.000192	0.00197	CcSEcCtD
Estriol—Eye disorder—Paclitaxel—ovarian cancer	0.00019	0.00195	CcSEcCtD
Estriol—Acute coronary syndrome—Docetaxel—ovarian cancer	0.000189	0.00194	CcSEcCtD
Estriol—Cardiac disorder—Paclitaxel—ovarian cancer	0.000188	0.00193	CcSEcCtD
Estriol—Myocardial infarction—Docetaxel—ovarian cancer	0.000188	0.00193	CcSEcCtD
Estriol—Vascular purpura—Epirubicin—ovarian cancer	0.000188	0.00193	CcSEcCtD
Estriol—Abnormal vision—Doxorubicin—ovarian cancer	0.000187	0.00192	CcSEcCtD
Estriol—Estradiol—ESR1—ovarian cancer	0.000186	0.0418	CrCbGaD
Estriol—Gastrointestinal disorder—Vinorelbine—ovarian cancer	0.000185	0.0019	CcSEcCtD
Estriol—Cardiac failure congestive—Epirubicin—ovarian cancer	0.000185	0.0019	CcSEcCtD
Estriol—Hypersensitivity—Topotecan—ovarian cancer	0.000185	0.0019	CcSEcCtD
Estriol—Angiopathy—Paclitaxel—ovarian cancer	0.000184	0.00189	CcSEcCtD
Estriol—Pain—Vinorelbine—ovarian cancer	0.000183	0.00188	CcSEcCtD
Estriol—Immune system disorder—Paclitaxel—ovarian cancer	0.000183	0.00188	CcSEcCtD
Estriol—Hepatobiliary disease—Docetaxel—ovarian cancer	0.000181	0.00186	CcSEcCtD
Estriol—Hypersensitivity—Melphalan—ovarian cancer	0.000181	0.00186	CcSEcCtD
Estriol—Alopecia—Paclitaxel—ovarian cancer	0.000179	0.00184	CcSEcCtD
Estriol—Thrombophlebitis—Doxorubicin—ovarian cancer	0.000179	0.00184	CcSEcCtD
Estriol—Vomiting—Chlorambucil—ovarian cancer	0.000179	0.00184	CcSEcCtD
Estriol—Mental disorder—Paclitaxel—ovarian cancer	0.000178	0.00183	CcSEcCtD
Estriol—Pruritus—Topotecan—ovarian cancer	0.000177	0.00182	CcSEcCtD
Estriol—Malnutrition—Paclitaxel—ovarian cancer	0.000177	0.00181	CcSEcCtD
Estriol—Gastrointestinal pain—Vinorelbine—ovarian cancer	0.000175	0.0018	CcSEcCtD
Estriol—Flatulence—Paclitaxel—ovarian cancer	0.000174	0.00179	CcSEcCtD
Estriol—Pruritus—Melphalan—ovarian cancer	0.000174	0.00178	CcSEcCtD
Estriol—Vascular purpura—Doxorubicin—ovarian cancer	0.000174	0.00178	CcSEcCtD
Estriol—Tension—Paclitaxel—ovarian cancer	0.000173	0.00178	CcSEcCtD
Estriol—Nervousness—Paclitaxel—ovarian cancer	0.000172	0.00176	CcSEcCtD
Estriol—Diarrhoea—Topotecan—ovarian cancer	0.000172	0.00176	CcSEcCtD
Estriol—Cerebrovascular accident—Epirubicin—ovarian cancer	0.000171	0.00176	CcSEcCtD
Estriol—Cardiac failure congestive—Doxorubicin—ovarian cancer	0.000171	0.00176	CcSEcCtD
Estriol—Back pain—Paclitaxel—ovarian cancer	0.000171	0.00176	CcSEcCtD
Estriol—Urticaria—Vinorelbine—ovarian cancer	0.00017	0.00175	CcSEcCtD
Estriol—Muscle spasms—Paclitaxel—ovarian cancer	0.00017	0.00174	CcSEcCtD
Estriol—Abdominal pain—Vinorelbine—ovarian cancer	0.00017	0.00174	CcSEcCtD
Estriol—Oedema peripheral—Docetaxel—ovarian cancer	0.00017	0.00174	CcSEcCtD
Estriol—Connective tissue disorder—Docetaxel—ovarian cancer	0.000169	0.00174	CcSEcCtD
Estriol—Diarrhoea—Melphalan—ovarian cancer	0.000168	0.00172	CcSEcCtD
Estriol—Nausea—Chlorambucil—ovarian cancer	0.000167	0.00172	CcSEcCtD
Estriol—Visual impairment—Docetaxel—ovarian cancer	0.000166	0.0017	CcSEcCtD
Estriol—Dizziness—Topotecan—ovarian cancer	0.000166	0.0017	CcSEcCtD
Estriol—Migraine—Epirubicin—ovarian cancer	0.000165	0.0017	CcSEcCtD
Estriol—Erythema multiforme—Docetaxel—ovarian cancer	0.000163	0.00167	CcSEcCtD
Estriol—Angioedema—Paclitaxel—ovarian cancer	0.000162	0.00166	CcSEcCtD
Estriol—Eye disorder—Docetaxel—ovarian cancer	0.000161	0.00165	CcSEcCtD
Estriol—ABCB1—lymph node—ovarian cancer	0.00016	0.00252	CbGeAlD
Estriol—Cardiac disorder—Docetaxel—ovarian cancer	0.00016	0.00164	CcSEcCtD
Estriol—Vomiting—Topotecan—ovarian cancer	0.000159	0.00164	CcSEcCtD
Estriol—Cerebrovascular accident—Doxorubicin—ovarian cancer	0.000158	0.00163	CcSEcCtD
Estriol—Rash—Topotecan—ovarian cancer	0.000158	0.00162	CcSEcCtD
Estriol—Hypersensitivity—Vinorelbine—ovarian cancer	0.000158	0.00162	CcSEcCtD
Estriol—Dermatitis—Topotecan—ovarian cancer	0.000158	0.00162	CcSEcCtD
Estriol—Headache—Topotecan—ovarian cancer	0.000157	0.00161	CcSEcCtD
Estriol—Angiopathy—Docetaxel—ovarian cancer	0.000156	0.0016	CcSEcCtD
Estriol—Vomiting—Melphalan—ovarian cancer	0.000156	0.0016	CcSEcCtD
Estriol—Immune system disorder—Docetaxel—ovarian cancer	0.000155	0.0016	CcSEcCtD
Estriol—Rash—Melphalan—ovarian cancer	0.000155	0.00159	CcSEcCtD
Estriol—Dermatitis—Melphalan—ovarian cancer	0.000155	0.00159	CcSEcCtD
Estriol—Migraine—Doxorubicin—ovarian cancer	0.000153	0.00157	CcSEcCtD
Estriol—Hypertension—Paclitaxel—ovarian cancer	0.000153	0.00157	CcSEcCtD
Estriol—Alopecia—Docetaxel—ovarian cancer	0.000152	0.00156	CcSEcCtD
Estriol—Pruritus—Vinorelbine—ovarian cancer	0.000152	0.00156	CcSEcCtD
Estriol—Breast disorder—Epirubicin—ovarian cancer	0.000152	0.00156	CcSEcCtD
Estriol—Mental disorder—Docetaxel—ovarian cancer	0.000151	0.00155	CcSEcCtD
Estriol—Anxiety—Paclitaxel—ovarian cancer	0.00015	0.00154	CcSEcCtD
Estriol—Malnutrition—Docetaxel—ovarian cancer	0.00015	0.00154	CcSEcCtD
Estriol—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—ovarian cancer	0.000149	0.00153	CcSEcCtD
Estriol—Nausea—Topotecan—ovarian cancer	0.000149	0.00153	CcSEcCtD
Estriol—Diarrhoea—Vinorelbine—ovarian cancer	0.000147	0.00151	CcSEcCtD
Estriol—Abdominal distension—Epirubicin—ovarian cancer	0.000146	0.0015	CcSEcCtD
Estriol—Nausea—Melphalan—ovarian cancer	0.000146	0.0015	CcSEcCtD
Estriol—Asthma—Epirubicin—ovarian cancer	0.000145	0.00149	CcSEcCtD
Estriol—Back pain—Docetaxel—ovarian cancer	0.000145	0.00149	CcSEcCtD
Estriol—Oedema—Paclitaxel—ovarian cancer	0.000144	0.00148	CcSEcCtD
Estriol—Anaphylactic shock—Paclitaxel—ovarian cancer	0.000144	0.00148	CcSEcCtD
Estriol—Muscle spasms—Docetaxel—ovarian cancer	0.000144	0.00148	CcSEcCtD
Estriol—Infection—Paclitaxel—ovarian cancer	0.000143	0.00147	CcSEcCtD
Estriol—Shock—Paclitaxel—ovarian cancer	0.000142	0.00146	CcSEcCtD
Estriol—Dizziness—Vinorelbine—ovarian cancer	0.000142	0.00146	CcSEcCtD
Estriol—Nervous system disorder—Paclitaxel—ovarian cancer	0.000141	0.00145	CcSEcCtD
Estriol—Breast disorder—Doxorubicin—ovarian cancer	0.00014	0.00144	CcSEcCtD
Estriol—Skin disorder—Paclitaxel—ovarian cancer	0.00014	0.00144	CcSEcCtD
Estriol—Vomiting—Vinorelbine—ovarian cancer	0.000136	0.0014	CcSEcCtD
Estriol—Rash—Vinorelbine—ovarian cancer	0.000135	0.00139	CcSEcCtD
Estriol—Dermatitis—Vinorelbine—ovarian cancer	0.000135	0.00139	CcSEcCtD
Estriol—Abdominal distension—Doxorubicin—ovarian cancer	0.000135	0.00139	CcSEcCtD
Estriol—Headache—Vinorelbine—ovarian cancer	0.000134	0.00138	CcSEcCtD
Estriol—Asthma—Doxorubicin—ovarian cancer	0.000134	0.00138	CcSEcCtD
Estriol—Weight increased—Epirubicin—ovarian cancer	0.000132	0.00136	CcSEcCtD
Estriol—Weight decreased—Epirubicin—ovarian cancer	0.000131	0.00135	CcSEcCtD
Estriol—Insomnia—Paclitaxel—ovarian cancer	0.00013	0.00134	CcSEcCtD
Estriol—Hypertension—Docetaxel—ovarian cancer	0.000129	0.00133	CcSEcCtD
Estriol—Infestation—Epirubicin—ovarian cancer	0.000129	0.00133	CcSEcCtD
Estriol—Infestation NOS—Epirubicin—ovarian cancer	0.000129	0.00133	CcSEcCtD
Estriol—Nausea—Vinorelbine—ovarian cancer	0.000127	0.00131	CcSEcCtD
Estriol—Dyspepsia—Paclitaxel—ovarian cancer	0.000127	0.0013	CcSEcCtD
Estriol—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—ovarian cancer	0.000127	0.0013	CcSEcCtD
Estriol—Gastrointestinal disorder—Paclitaxel—ovarian cancer	0.000125	0.00128	CcSEcCtD
Estriol—Pain—Paclitaxel—ovarian cancer	0.000123	0.00127	CcSEcCtD
Estriol—Hepatobiliary disease—Epirubicin—ovarian cancer	0.000122	0.00126	CcSEcCtD
Estriol—Anaphylactic shock—Docetaxel—ovarian cancer	0.000122	0.00126	CcSEcCtD
Estriol—Oedema—Docetaxel—ovarian cancer	0.000122	0.00126	CcSEcCtD
Estriol—Weight increased—Doxorubicin—ovarian cancer	0.000122	0.00125	CcSEcCtD
Estriol—Infection—Docetaxel—ovarian cancer	0.000121	0.00125	CcSEcCtD
Estriol—Weight decreased—Doxorubicin—ovarian cancer	0.000121	0.00125	CcSEcCtD
Estriol—Shock—Docetaxel—ovarian cancer	0.00012	0.00124	CcSEcCtD
Estriol—Nervous system disorder—Docetaxel—ovarian cancer	0.00012	0.00123	CcSEcCtD
Estriol—Infestation—Doxorubicin—ovarian cancer	0.00012	0.00123	CcSEcCtD
Estriol—Infestation NOS—Doxorubicin—ovarian cancer	0.00012	0.00123	CcSEcCtD
Estriol—Ethinyl Estradiol—ABCB1—ovarian cancer	0.000119	0.0269	CrCbGaD
Estriol—Skin disorder—Docetaxel—ovarian cancer	0.000119	0.00122	CcSEcCtD
Estriol—Gastrointestinal pain—Paclitaxel—ovarian cancer	0.000118	0.00121	CcSEcCtD
Estriol—Urticaria—Paclitaxel—ovarian cancer	0.000115	0.00118	CcSEcCtD
Estriol—Oedema peripheral—Epirubicin—ovarian cancer	0.000114	0.00117	CcSEcCtD
Estriol—Connective tissue disorder—Epirubicin—ovarian cancer	0.000114	0.00117	CcSEcCtD
Estriol—Abdominal pain—Paclitaxel—ovarian cancer	0.000114	0.00117	CcSEcCtD
Estriol—Hepatobiliary disease—Doxorubicin—ovarian cancer	0.000113	0.00116	CcSEcCtD
Estriol—Visual impairment—Epirubicin—ovarian cancer	0.000112	0.00115	CcSEcCtD
Estriol—Insomnia—Docetaxel—ovarian cancer	0.000111	0.00114	CcSEcCtD
Estriol—Erythema multiforme—Epirubicin—ovarian cancer	0.00011	0.00113	CcSEcCtD
Estriol—Eye disorder—Epirubicin—ovarian cancer	0.000108	0.00111	CcSEcCtD
Estriol—Cardiac disorder—Epirubicin—ovarian cancer	0.000108	0.00111	CcSEcCtD
Estriol—Dyspepsia—Docetaxel—ovarian cancer	0.000108	0.00111	CcSEcCtD
Estriol—Hypersensitivity—Paclitaxel—ovarian cancer	0.000106	0.00109	CcSEcCtD
Estriol—Oedema peripheral—Doxorubicin—ovarian cancer	0.000106	0.00109	CcSEcCtD
Estriol—Gastrointestinal disorder—Docetaxel—ovarian cancer	0.000106	0.00108	CcSEcCtD
Estriol—Connective tissue disorder—Doxorubicin—ovarian cancer	0.000106	0.00108	CcSEcCtD
Estriol—Angiopathy—Epirubicin—ovarian cancer	0.000105	0.00108	CcSEcCtD
Estriol—Immune system disorder—Epirubicin—ovarian cancer	0.000105	0.00108	CcSEcCtD
Estriol—Pain—Docetaxel—ovarian cancer	0.000105	0.00107	CcSEcCtD
Estriol—Conjugated Estrogens—ABCB1—ovarian cancer	0.000104	0.0235	CrCbGaD
Estriol—Estrone—ABCB1—ovarian cancer	0.000104	0.0234	CrCbGaD
Estriol—Visual impairment—Doxorubicin—ovarian cancer	0.000104	0.00106	CcSEcCtD
Estriol—Alopecia—Epirubicin—ovarian cancer	0.000103	0.00105	CcSEcCtD
Estriol—Pruritus—Paclitaxel—ovarian cancer	0.000102	0.00105	CcSEcCtD
Estriol—Mental disorder—Epirubicin—ovarian cancer	0.000102	0.00104	CcSEcCtD
Estriol—Erythema multiforme—Doxorubicin—ovarian cancer	0.000102	0.00104	CcSEcCtD
Estriol—Malnutrition—Epirubicin—ovarian cancer	0.000101	0.00104	CcSEcCtD
Estriol—Eye disorder—Doxorubicin—ovarian cancer	0.0001	0.00103	CcSEcCtD
Estriol—Gastrointestinal pain—Docetaxel—ovarian cancer	0.0001	0.00103	CcSEcCtD
Estriol—Cardiac disorder—Doxorubicin—ovarian cancer	9.97e-05	0.00102	CcSEcCtD
Estriol—Flatulence—Epirubicin—ovarian cancer	9.96e-05	0.00102	CcSEcCtD
Estriol—Tension—Epirubicin—ovarian cancer	9.92e-05	0.00102	CcSEcCtD
Estriol—Diarrhoea—Paclitaxel—ovarian cancer	9.87e-05	0.00101	CcSEcCtD
Estriol—Nervousness—Epirubicin—ovarian cancer	9.81e-05	0.00101	CcSEcCtD
Estriol—Back pain—Epirubicin—ovarian cancer	9.77e-05	0.001	CcSEcCtD
Estriol—Angiopathy—Doxorubicin—ovarian cancer	9.74e-05	0.001	CcSEcCtD
Estriol—Muscle spasms—Epirubicin—ovarian cancer	9.72e-05	0.000998	CcSEcCtD
Estriol—Immune system disorder—Doxorubicin—ovarian cancer	9.7e-05	0.000996	CcSEcCtD
Estriol—Abdominal pain—Docetaxel—ovarian cancer	9.67e-05	0.000992	CcSEcCtD
Estriol—Dizziness—Paclitaxel—ovarian cancer	9.54e-05	0.000979	CcSEcCtD
Estriol—Alopecia—Doxorubicin—ovarian cancer	9.49e-05	0.000975	CcSEcCtD
Estriol—Mental disorder—Doxorubicin—ovarian cancer	9.41e-05	0.000966	CcSEcCtD
Estriol—Malnutrition—Doxorubicin—ovarian cancer	9.35e-05	0.00096	CcSEcCtD
Estriol—Flatulence—Doxorubicin—ovarian cancer	9.21e-05	0.000946	CcSEcCtD
Estriol—Tension—Doxorubicin—ovarian cancer	9.18e-05	0.000942	CcSEcCtD
Estriol—Vomiting—Paclitaxel—ovarian cancer	9.17e-05	0.000942	CcSEcCtD
Estriol—Rash—Paclitaxel—ovarian cancer	9.1e-05	0.000934	CcSEcCtD
Estriol—Dermatitis—Paclitaxel—ovarian cancer	9.09e-05	0.000933	CcSEcCtD
Estriol—Nervousness—Doxorubicin—ovarian cancer	9.08e-05	0.000932	CcSEcCtD
Estriol—Back pain—Doxorubicin—ovarian cancer	9.04e-05	0.000929	CcSEcCtD
Estriol—Headache—Paclitaxel—ovarian cancer	9.04e-05	0.000928	CcSEcCtD
Estriol—Hypersensitivity—Docetaxel—ovarian cancer	9.01e-05	0.000925	CcSEcCtD
Estriol—Muscle spasms—Doxorubicin—ovarian cancer	8.99e-05	0.000923	CcSEcCtD
Estriol—ESR1—AP-1 transcription factor network—IL2—ovarian cancer	8.96e-05	0.00169	CbGpPWpGaD
Estriol—ESR1—Regulation of Telomerase—CCND1—ovarian cancer	8.94e-05	0.00169	CbGpPWpGaD
Estriol—ESR2—Integrated Pancreatic Cancer Pathway—ERBB2—ovarian cancer	8.79e-05	0.00166	CbGpPWpGaD
Estriol—ESR1—AP-1 transcription factor network—CCND1—ovarian cancer	8.74e-05	0.00165	CbGpPWpGaD
Estriol—Hypertension—Epirubicin—ovarian cancer	8.72e-05	0.000896	CcSEcCtD
Estriol—ESR1—AP-1 transcription factor network—CTNNB1—ovarian cancer	8.65e-05	0.00163	CbGpPWpGaD
Estriol—Pruritus—Docetaxel—ovarian cancer	8.65e-05	0.000888	CcSEcCtD
Estriol—Anxiety—Epirubicin—ovarian cancer	8.57e-05	0.00088	CcSEcCtD
Estriol—Nausea—Paclitaxel—ovarian cancer	8.57e-05	0.00088	CcSEcCtD
Estriol—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—ovarian cancer	8.54e-05	0.000877	CcSEcCtD
Estriol—ESR1—LKB1 signaling events—TP53—ovarian cancer	8.5e-05	0.00161	CbGpPWpGaD
Estriol—ESR1—AP-1 transcription factor network—MMP9—ovarian cancer	8.48e-05	0.0016	CbGpPWpGaD
Estriol—ESR1—Plasma membrane estrogen receptor signaling—HRAS—ovarian cancer	8.45e-05	0.00159	CbGpPWpGaD
Estriol—ESR1—AP-1 transcription factor network—PTEN—ovarian cancer	8.44e-05	0.00159	CbGpPWpGaD
Estriol—ABCB1—HIF-1-alpha transcription factor network—TERT—ovarian cancer	8.39e-05	0.00158	CbGpPWpGaD
Estriol—Diarrhoea—Docetaxel—ovarian cancer	8.37e-05	0.000859	CcSEcCtD
Estriol—ESR1—Leptin signaling pathway—CCND1—ovarian cancer	8.27e-05	0.00156	CbGpPWpGaD
Estriol—ESR1—ATF-2 transcription factor network—MAPK3—ovarian cancer	8.26e-05	0.00156	CbGpPWpGaD
Estriol—Oedema—Epirubicin—ovarian cancer	8.25e-05	0.000847	CcSEcCtD
Estriol—Anaphylactic shock—Epirubicin—ovarian cancer	8.25e-05	0.000847	CcSEcCtD
Estriol—Infection—Epirubicin—ovarian cancer	8.19e-05	0.000841	CcSEcCtD
Estriol—ESR1—Integrated Pancreatic Cancer Pathway—BRCA2—ovarian cancer	8.17e-05	0.00154	CbGpPWpGaD
Estriol—ESR2—Integrated Pancreatic Cancer Pathway—CDKN1B—ovarian cancer	8.14e-05	0.00154	CbGpPWpGaD
Estriol—Shock—Epirubicin—ovarian cancer	8.11e-05	0.000833	CcSEcCtD
Estriol—Nervous system disorder—Epirubicin—ovarian cancer	8.09e-05	0.00083	CcSEcCtD
Estriol—Dizziness—Docetaxel—ovarian cancer	8.09e-05	0.00083	CcSEcCtD
Estriol—Hypertension—Doxorubicin—ovarian cancer	8.07e-05	0.000829	CcSEcCtD
Estriol—Skin disorder—Epirubicin—ovarian cancer	8.01e-05	0.000823	CcSEcCtD
Estriol—ESR2—Integrated Pancreatic Cancer Pathway—CASP3—ovarian cancer	7.98e-05	0.00151	CbGpPWpGaD
Estriol—ESR2—SIDS Susceptibility Pathways—VEGFA—ovarian cancer	7.96e-05	0.0015	CbGpPWpGaD
Estriol—Anxiety—Doxorubicin—ovarian cancer	7.93e-05	0.000814	CcSEcCtD
Estriol—ESR1—Integrated Pancreatic Cancer Pathway—CCNE1—ovarian cancer	7.92e-05	0.00149	CbGpPWpGaD
Estriol—ESR1—Integrated Pancreatic Cancer Pathway—ABCB1—ovarian cancer	7.92e-05	0.00149	CbGpPWpGaD
Estriol—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—ovarian cancer	7.91e-05	0.000812	CcSEcCtD
Estriol—Estradiol—ABCB1—ovarian cancer	7.88e-05	0.0177	CrCbGaD
Estriol—SLCO1A2—Metabolism—NME2—ovarian cancer	7.88e-05	0.00149	CbGpPWpGaD
Estriol—ESR1—ATF-2 transcription factor network—MAPK1—ovarian cancer	7.86e-05	0.00148	CbGpPWpGaD
Estriol—ESR1—Integrated Pancreatic Cancer Pathway—TYMS—ovarian cancer	7.78e-05	0.00147	CbGpPWpGaD
Estriol—Vomiting—Docetaxel—ovarian cancer	7.77e-05	0.000798	CcSEcCtD
Estriol—ESR2—Integrated Pancreatic Cancer Pathway—CCND1—ovarian cancer	7.76e-05	0.00147	CbGpPWpGaD
Estriol—Rash—Docetaxel—ovarian cancer	7.71e-05	0.000792	CcSEcCtD
Estriol—ESR1—Aryl Hydrocarbon Receptor—HRAS—ovarian cancer	7.7e-05	0.00145	CbGpPWpGaD
Estriol—Dermatitis—Docetaxel—ovarian cancer	7.7e-05	0.000791	CcSEcCtD
Estriol—ESR2—Integrated Pancreatic Cancer Pathway—CTNNB1—ovarian cancer	7.69e-05	0.00145	CbGpPWpGaD
Estriol—Headache—Docetaxel—ovarian cancer	7.66e-05	0.000786	CcSEcCtD
Estriol—SLCO1A2—Transmembrane transport of small molecules—TUBB3—ovarian cancer	7.64e-05	0.00144	CbGpPWpGaD
Estriol—Anaphylactic shock—Doxorubicin—ovarian cancer	7.63e-05	0.000784	CcSEcCtD
Estriol—Oedema—Doxorubicin—ovarian cancer	7.63e-05	0.000784	CcSEcCtD
Estriol—ESR1—Gene Expression—WDR77—ovarian cancer	7.62e-05	0.00144	CbGpPWpGaD
Estriol—Infection—Doxorubicin—ovarian cancer	7.58e-05	0.000778	CcSEcCtD
Estriol—ESR1—Validated nuclear estrogen receptor alpha network—MYC—ovarian cancer	7.53e-05	0.00142	CbGpPWpGaD
Estriol—Shock—Doxorubicin—ovarian cancer	7.51e-05	0.000771	CcSEcCtD
Estriol—ESR2—Integrated Pancreatic Cancer Pathway—PTEN—ovarian cancer	7.49e-05	0.00142	CbGpPWpGaD
Estriol—Nervous system disorder—Doxorubicin—ovarian cancer	7.48e-05	0.000768	CcSEcCtD
Estriol—Insomnia—Epirubicin—ovarian cancer	7.46e-05	0.000766	CcSEcCtD
Estriol—ESR1—Plasma membrane estrogen receptor signaling—AKT1—ovarian cancer	7.46e-05	0.00141	CbGpPWpGaD
Estriol—Skin disorder—Doxorubicin—ovarian cancer	7.41e-05	0.000761	CcSEcCtD
Estriol—ESR1—Regulation of Telomerase—MAPK3—ovarian cancer	7.38e-05	0.00139	CbGpPWpGaD
Estriol—Nausea—Docetaxel—ovarian cancer	7.26e-05	0.000746	CcSEcCtD
Estriol—Dyspepsia—Epirubicin—ovarian cancer	7.26e-05	0.000745	CcSEcCtD
Estriol—ESR1—Regulation of Telomerase—MYC—ovarian cancer	7.17e-05	0.00135	CbGpPWpGaD
Estriol—ESR1—Leptin signaling pathway—STAT3—ovarian cancer	7.14e-05	0.00135	CbGpPWpGaD
Estriol—ESR1—Signaling by ERBB4—IL6ST—ovarian cancer	7.13e-05	0.00135	CbGpPWpGaD
Estriol—Gastrointestinal disorder—Epirubicin—ovarian cancer	7.12e-05	0.000731	CcSEcCtD
Estriol—Pain—Epirubicin—ovarian cancer	7.05e-05	0.000724	CcSEcCtD
Estriol—ESR1—Regulation of Telomerase—MAPK1—ovarian cancer	7.02e-05	0.00133	CbGpPWpGaD
Estriol—ESR1—Regulation of Telomerase—EGFR—ovarian cancer	7.02e-05	0.00133	CbGpPWpGaD
Estriol—ESR1—AP-1 transcription factor network—MYC—ovarian cancer	7.01e-05	0.00132	CbGpPWpGaD
Estriol—Insomnia—Doxorubicin—ovarian cancer	6.9e-05	0.000709	CcSEcCtD
Estriol—ESR1—Leptin signaling pathway—MAPK3—ovarian cancer	6.82e-05	0.00129	CbGpPWpGaD
Estriol—ESR2—Integrated Pancreatic Cancer Pathway—VEGFA—ovarian cancer	6.77e-05	0.00128	CbGpPWpGaD
Estriol—Gastrointestinal pain—Epirubicin—ovarian cancer	6.74e-05	0.000692	CcSEcCtD
Estriol—Dyspepsia—Doxorubicin—ovarian cancer	6.72e-05	0.00069	CcSEcCtD
Estriol—SLCO1A2—Metabolism of lipids and lipoproteins—YAP1—ovarian cancer	6.68e-05	0.00126	CbGpPWpGaD
Estriol—Gastrointestinal disorder—Doxorubicin—ovarian cancer	6.59e-05	0.000676	CcSEcCtD
Estriol—Urticaria—Epirubicin—ovarian cancer	6.55e-05	0.000673	CcSEcCtD
Estriol—Pain—Doxorubicin—ovarian cancer	6.53e-05	0.00067	CcSEcCtD
Estriol—Abdominal pain—Epirubicin—ovarian cancer	6.52e-05	0.000669	CcSEcCtD
Estriol—ESR1—Leptin signaling pathway—MAPK1—ovarian cancer	6.49e-05	0.00123	CbGpPWpGaD
Estriol—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—CDKN1B—ovarian cancer	6.45e-05	0.00122	CbGpPWpGaD
Estriol—ESR1—Generic Transcription Pathway—YAP1—ovarian cancer	6.43e-05	0.00121	CbGpPWpGaD
Estriol—ESR2—Integrated Pancreatic Cancer Pathway—MAPK3—ovarian cancer	6.4e-05	0.00121	CbGpPWpGaD
Estriol—ESR1—Integrated Breast Cancer Pathway—CDH1—ovarian cancer	6.34e-05	0.0012	CbGpPWpGaD
Estriol—Gastrointestinal pain—Doxorubicin—ovarian cancer	6.24e-05	0.000641	CcSEcCtD
Estriol—ESR1—Regulation of nuclear SMAD2/3 signaling—MYC—ovarian cancer	6.24e-05	0.00118	CbGpPWpGaD
Estriol—ESR2—Integrated Pancreatic Cancer Pathway—MYC—ovarian cancer	6.23e-05	0.00118	CbGpPWpGaD
Estriol—ESR2—Gene Expression—YAP1—ovarian cancer	6.14e-05	0.00116	CbGpPWpGaD
Estriol—ESR2—Integrated Pancreatic Cancer Pathway—MAPK1—ovarian cancer	6.09e-05	0.00115	CbGpPWpGaD
Estriol—ESR2—Integrated Pancreatic Cancer Pathway—EGFR—ovarian cancer	6.09e-05	0.00115	CbGpPWpGaD
Estriol—Hypersensitivity—Epirubicin—ovarian cancer	6.08e-05	0.000624	CcSEcCtD
Estriol—Urticaria—Doxorubicin—ovarian cancer	6.06e-05	0.000622	CcSEcCtD
Estriol—ESR1—ATF-2 transcription factor network—IL6—ovarian cancer	6.04e-05	0.00114	CbGpPWpGaD
Estriol—Abdominal pain—Doxorubicin—ovarian cancer	6.03e-05	0.000619	CcSEcCtD
Estriol—ESR1—Signaling by ERBB4—PIK3CD—ovarian cancer	6.02e-05	0.00114	CbGpPWpGaD
Estriol—ESR1—Gene Expression—TTF1—ovarian cancer	5.98e-05	0.00113	CbGpPWpGaD
Estriol—ESR2—Generic Transcription Pathway—ESR1—ovarian cancer	5.95e-05	0.00112	CbGpPWpGaD
Estriol—Pruritus—Epirubicin—ovarian cancer	5.83e-05	0.000599	CcSEcCtD
Estriol—ESR1—Signaling Pathways—HSD17B6—ovarian cancer	5.83e-05	0.0011	CbGpPWpGaD
Estriol—ESR1—AP-1 transcription factor network—TP53—ovarian cancer	5.76e-05	0.00109	CbGpPWpGaD
Estriol—ESR2—Integrated Pancreatic Cancer Pathway—KRAS—ovarian cancer	5.75e-05	0.00109	CbGpPWpGaD
Estriol—ESR1—Integrated Pancreatic Cancer Pathway—APC—ovarian cancer	5.71e-05	0.00108	CbGpPWpGaD
Estriol—Diarrhoea—Epirubicin—ovarian cancer	5.64e-05	0.000579	CcSEcCtD
Estriol—Hypersensitivity—Doxorubicin—ovarian cancer	5.62e-05	0.000577	CcSEcCtD
Estriol—ESR1—Generic Transcription Pathway—PGR—ovarian cancer	5.62e-05	0.00106	CbGpPWpGaD
Estriol—ABCB1—Integrated Pancreatic Cancer Pathway—GADD45A—ovarian cancer	5.58e-05	0.00105	CbGpPWpGaD
Estriol—ESR2—SIDS Susceptibility Pathways—IL6—ovarian cancer	5.5e-05	0.00104	CbGpPWpGaD
Estriol—Dizziness—Epirubicin—ovarian cancer	5.45e-05	0.00056	CcSEcCtD
Estriol—SLCO1A2—Metabolism of lipids and lipoproteins—FASN—ovarian cancer	5.45e-05	0.00103	CbGpPWpGaD
Estriol—ESR1—Gene Expression—NR5A1—ovarian cancer	5.43e-05	0.00103	CbGpPWpGaD
Estriol—Pruritus—Doxorubicin—ovarian cancer	5.4e-05	0.000554	CcSEcCtD
Estriol—ESR2—Gene Expression—PGR—ovarian cancer	5.36e-05	0.00101	CbGpPWpGaD
Estriol—ESR1—Signaling by ERBB4—ERBB2—ovarian cancer	5.32e-05	0.001	CbGpPWpGaD
Estriol—ESR2—Integrated Pancreatic Cancer Pathway—PIK3CA—ovarian cancer	5.29e-05	0.000998	CbGpPWpGaD
Estriol—ESR1—Integrated Breast Cancer Pathway—MTOR—ovarian cancer	5.28e-05	0.000997	CbGpPWpGaD
Estriol—ESR1—AP-1 transcription factor network—IL6—ovarian cancer	5.27e-05	0.000995	CbGpPWpGaD
Estriol—ESR1—Signaling by ERBB4—MTOR—ovarian cancer	5.25e-05	0.000991	CbGpPWpGaD
Estriol—ESR1—Signaling by ERBB4—PIK3CB—ovarian cancer	5.25e-05	0.000991	CbGpPWpGaD
Estriol—Vomiting—Epirubicin—ovarian cancer	5.24e-05	0.000538	CcSEcCtD
Estriol—ESR1—Generic Transcription Pathway—PARP1—ovarian cancer	5.22e-05	0.000986	CbGpPWpGaD
Estriol—Diarrhoea—Doxorubicin—ovarian cancer	5.22e-05	0.000536	CcSEcCtD
Estriol—ESR1—Leptin signaling pathway—HRAS—ovarian cancer	5.21e-05	0.000984	CbGpPWpGaD
Estriol—Rash—Epirubicin—ovarian cancer	5.2e-05	0.000534	CcSEcCtD
Estriol—Dermatitis—Epirubicin—ovarian cancer	5.2e-05	0.000533	CcSEcCtD
Estriol—Headache—Epirubicin—ovarian cancer	5.17e-05	0.00053	CcSEcCtD
Estriol—ESR2—Integrated Pancreatic Cancer Pathway—TP53—ovarian cancer	5.11e-05	0.000966	CbGpPWpGaD
Estriol—ABCB1—Integrated Pancreatic Cancer Pathway—CHEK2—ovarian cancer	5.1e-05	0.000964	CbGpPWpGaD
Estriol—SLCO1A2—Transmembrane transport of small molecules—SLC5A5—ovarian cancer	5.1e-05	0.000962	CbGpPWpGaD
Estriol—SLCO1A2—Metabolism—CYTB—ovarian cancer	5.08e-05	0.000959	CbGpPWpGaD
Estriol—Dizziness—Doxorubicin—ovarian cancer	5.05e-05	0.000518	CcSEcCtD
Estriol—ESR2—Gene Expression—PARP1—ovarian cancer	4.99e-05	0.000941	CbGpPWpGaD
Estriol—ESR1—Regulation of Telomerase—AKT1—ovarian cancer	4.98e-05	0.000939	CbGpPWpGaD
Estriol—SLCO1A2—Metabolism of lipids and lipoproteins—CYP1B1—ovarian cancer	4.96e-05	0.000937	CbGpPWpGaD
Estriol—ESR1—Signaling Pathways—DLC1—ovarian cancer	4.95e-05	0.000936	CbGpPWpGaD
Estriol—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—ovarian cancer	4.93e-05	0.000932	CbGpPWpGaD
Estriol—ESR1—Signaling by ERBB4—CDKN1B—ovarian cancer	4.93e-05	0.00093	CbGpPWpGaD
Estriol—SLCO1A2—Transmembrane transport of small molecules—SLC2A1—ovarian cancer	4.92e-05	0.000929	CbGpPWpGaD
Estriol—Nausea—Epirubicin—ovarian cancer	4.9e-05	0.000503	CcSEcCtD
Estriol—ESR1—Integrated Breast Cancer Pathway—CASP3—ovarian cancer	4.85e-05	0.000917	CbGpPWpGaD
Estriol—Vomiting—Doxorubicin—ovarian cancer	4.85e-05	0.000498	CcSEcCtD
Estriol—Rash—Doxorubicin—ovarian cancer	4.81e-05	0.000494	CcSEcCtD
Estriol—Dermatitis—Doxorubicin—ovarian cancer	4.81e-05	0.000494	CcSEcCtD
Estriol—ABCB1—Integrated Pancreatic Cancer Pathway—BRCA1—ovarian cancer	4.78e-05	0.000903	CbGpPWpGaD
Estriol—Headache—Doxorubicin—ovarian cancer	4.78e-05	0.000491	CcSEcCtD
Estriol—ESR1—Integrated Breast Cancer Pathway—CCND1—ovarian cancer	4.72e-05	0.000892	CbGpPWpGaD
Estriol—ESR1—Integrated Breast Cancer Pathway—CTNNB1—ovarian cancer	4.68e-05	0.000883	CbGpPWpGaD
Estriol—ESR1—Leptin signaling pathway—AKT1—ovarian cancer	4.6e-05	0.000869	CbGpPWpGaD
Estriol—ESR1—Integrated Breast Cancer Pathway—PTEN—ovarian cancer	4.56e-05	0.000861	CbGpPWpGaD
Estriol—ESR1—Signaling by ERBB4—PTEN—ovarian cancer	4.54e-05	0.000857	CbGpPWpGaD
Estriol—Nausea—Doxorubicin—ovarian cancer	4.53e-05	0.000465	CcSEcCtD
Estriol—ABCB1—Allograft Rejection—CXCL8—ovarian cancer	4.51e-05	0.000851	CbGpPWpGaD
Estriol—SLCO1A2—Metabolism—PPP1CC—ovarian cancer	4.44e-05	0.000838	CbGpPWpGaD
Estriol—SLCO1A2—Metabolism—BRIP1—ovarian cancer	4.44e-05	0.000838	CbGpPWpGaD
Estriol—ESR1—Integrated Pancreatic Cancer Pathway—ERBB2—ovarian cancer	4.43e-05	0.000837	CbGpPWpGaD
Estriol—ESR1—Regulation of nuclear SMAD2/3 signaling—AKT1—ovarian cancer	4.33e-05	0.000817	CbGpPWpGaD
Estriol—ABCB1—Integrated Pancreatic Cancer Pathway—BRCA2—ovarian cancer	4.33e-05	0.000817	CbGpPWpGaD
Estriol—ESR2—Integrated Pancreatic Cancer Pathway—AKT1—ovarian cancer	4.32e-05	0.000815	CbGpPWpGaD
Estriol—ABCB1—Transmembrane transport of small molecules—AQP3—ovarian cancer	4.31e-05	0.000815	CbGpPWpGaD
Estriol—ABCB1—Allograft Rejection—CASP3—ovarian cancer	4.31e-05	0.000814	CbGpPWpGaD
Estriol—ABCB1—Allograft Rejection—IL2—ovarian cancer	4.31e-05	0.000813	CbGpPWpGaD
Estriol—ABCB1—HIF-1-alpha transcription factor network—VEGFA—ovarian cancer	4.23e-05	0.000798	CbGpPWpGaD
Estriol—ABCB1—Integrated Pancreatic Cancer Pathway—CCNE1—ovarian cancer	4.19e-05	0.000791	CbGpPWpGaD
Estriol—ABCB1—Transmembrane transport of small molecules—ATP7B—ovarian cancer	4.14e-05	0.000781	CbGpPWpGaD
Estriol—ESR1—Integrated Breast Cancer Pathway—VEGFA—ovarian cancer	4.12e-05	0.000778	CbGpPWpGaD
Estriol—ABCB1—Integrated Pancreatic Cancer Pathway—TYMS—ovarian cancer	4.11e-05	0.000777	CbGpPWpGaD
Estriol—ESR1—Integrated Pancreatic Cancer Pathway—CDKN1B—ovarian cancer	4.1e-05	0.000775	CbGpPWpGaD
Estriol—ESR1—Signaling by ERBB4—NRAS—ovarian cancer	4.05e-05	0.000764	CbGpPWpGaD
Estriol—ESR2—Gene Expression—PPP2R1A—ovarian cancer	4.04e-05	0.000764	CbGpPWpGaD
Estriol—ESR1—Signaling Pathways—BCL9—ovarian cancer	4.04e-05	0.000763	CbGpPWpGaD
Estriol—ESR1—Integrated Pancreatic Cancer Pathway—CASP3—ovarian cancer	4.02e-05	0.000759	CbGpPWpGaD
Estriol—ESR1—Integrated Pancreatic Cancer Pathway—CCND1—ovarian cancer	3.91e-05	0.000739	CbGpPWpGaD
Estriol—SLCO1A2—Transmembrane transport of small molecules—ABCB1—ovarian cancer	3.88e-05	0.000734	CbGpPWpGaD
Estriol—ESR1—Integrated Pancreatic Cancer Pathway—CTNNB1—ovarian cancer	3.88e-05	0.000732	CbGpPWpGaD
Estriol—ESR1—Signaling by ERBB4—MAPK3—ovarian cancer	3.88e-05	0.000732	CbGpPWpGaD
Estriol—ESR1—Integrated Breast Cancer Pathway—MYC—ovarian cancer	3.79e-05	0.000716	CbGpPWpGaD
Estriol—ESR1—Integrated Pancreatic Cancer Pathway—PTEN—ovarian cancer	3.78e-05	0.000714	CbGpPWpGaD
Estriol—ESR1—Integrated Breast Cancer Pathway—MAPK1—ovarian cancer	3.71e-05	0.0007	CbGpPWpGaD
Estriol—ESR1—Integrated Breast Cancer Pathway—EGFR—ovarian cancer	3.71e-05	0.0007	CbGpPWpGaD
Estriol—ESR1—Signaling by ERBB4—MAPK1—ovarian cancer	3.69e-05	0.000696	CbGpPWpGaD
Estriol—ESR1—Signaling by ERBB4—EGFR—ovarian cancer	3.69e-05	0.000696	CbGpPWpGaD
Estriol—ABCB1—Allograft Rejection—VEGFA—ovarian cancer	3.66e-05	0.000691	CbGpPWpGaD
Estriol—ESR1—Integrated Breast Cancer Pathway—KRAS—ovarian cancer	3.5e-05	0.000661	CbGpPWpGaD
Estriol—ESR1—Signaling by ERBB4—KRAS—ovarian cancer	3.48e-05	0.000658	CbGpPWpGaD
Estriol—ESR1—Integrated Pancreatic Cancer Pathway—VEGFA—ovarian cancer	3.41e-05	0.000644	CbGpPWpGaD
Estriol—ABCB1—Metabolism—NME2—ovarian cancer	3.37e-05	0.000637	CbGpPWpGaD
Estriol—ABCB1—Transmembrane transport of small molecules—TUBB3—ovarian cancer	3.27e-05	0.000617	CbGpPWpGaD
Estriol—SLCO1A2—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	3.23e-05	0.000611	CbGpPWpGaD
Estriol—ESR1—Integrated Pancreatic Cancer Pathway—MAPK3—ovarian cancer	3.23e-05	0.00061	CbGpPWpGaD
Estriol—ESR1—Signaling by ERBB4—PIK3CA—ovarian cancer	3.2e-05	0.000604	CbGpPWpGaD
Estriol—ABCB1—Integrated Pancreatic Cancer Pathway—ESR1—ovarian cancer	3.19e-05	0.000603	CbGpPWpGaD
Estriol—ESR1—Signaling Pathways—DOK1—ovarian cancer	3.19e-05	0.000603	CbGpPWpGaD
Estriol—ESR1—Integrated Pancreatic Cancer Pathway—MYC—ovarian cancer	3.14e-05	0.000593	CbGpPWpGaD
Estriol—ESR1—Integrated Breast Cancer Pathway—TP53—ovarian cancer	3.11e-05	0.000588	CbGpPWpGaD
Estriol—ESR1—Gene Expression—YAP1—ovarian cancer	3.1e-05	0.000585	CbGpPWpGaD
Estriol—ESR2—Generic Transcription Pathway—MYC—ovarian cancer	3.09e-05	0.000584	CbGpPWpGaD
Estriol—ESR1—Integrated Pancreatic Cancer Pathway—MAPK1—ovarian cancer	3.07e-05	0.00058	CbGpPWpGaD
Estriol—ESR1—Integrated Pancreatic Cancer Pathway—EGFR—ovarian cancer	3.07e-05	0.00058	CbGpPWpGaD
Estriol—ABCB1—Integrated Pancreatic Cancer Pathway—APC—ovarian cancer	3.02e-05	0.00057	CbGpPWpGaD
Estriol—ESR1—Signaling Pathways—PPP1CC—ovarian cancer	3e-05	0.000567	CbGpPWpGaD
Estriol—SLCO1A2—Metabolism—YAP1—ovarian cancer	2.98e-05	0.000562	CbGpPWpGaD
Estriol—ESR1—Signaling by ERBB4—HRAS—ovarian cancer	2.96e-05	0.000559	CbGpPWpGaD
Estriol—SLCO1A2—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	2.95e-05	0.000556	CbGpPWpGaD
Estriol—ESR1—Integrated Pancreatic Cancer Pathway—KRAS—ovarian cancer	2.9e-05	0.000548	CbGpPWpGaD
Estriol—ESR2—Gene Expression—ESR1—ovarian cancer	2.86e-05	0.000541	CbGpPWpGaD
Estriol—ESR1—Signaling by ERBB4—IL6—ovarian cancer	2.83e-05	0.000535	CbGpPWpGaD
Estriol—ESR1—Gene Expression—PGR—ovarian cancer	2.7e-05	0.000511	CbGpPWpGaD
Estriol—ABCB1—HIF-1-alpha transcription factor network—AKT1—ovarian cancer	2.7e-05	0.000509	CbGpPWpGaD
Estriol—ESR1—Integrated Pancreatic Cancer Pathway—PIK3CA—ovarian cancer	2.67e-05	0.000503	CbGpPWpGaD
Estriol—ESR1—Integrated Breast Cancer Pathway—AKT1—ovarian cancer	2.63e-05	0.000496	CbGpPWpGaD
Estriol—ESR1—Signaling by ERBB4—AKT1—ovarian cancer	2.61e-05	0.000494	CbGpPWpGaD
Estriol—SLCO1A2—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	2.59e-05	0.000489	CbGpPWpGaD
Estriol—ESR1—Integrated Pancreatic Cancer Pathway—TP53—ovarian cancer	2.58e-05	0.000487	CbGpPWpGaD
Estriol—ESR1—Gene Expression—PARP1—ovarian cancer	2.51e-05	0.000475	CbGpPWpGaD
Estriol—SLCO1A2—Metabolism—FASN—ovarian cancer	2.43e-05	0.000458	CbGpPWpGaD
Estriol—SLCO1A2—Metabolism—SLC5A5—ovarian cancer	2.39e-05	0.000451	CbGpPWpGaD
Estriol—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—ovarian cancer	2.34e-05	0.000443	CbGpPWpGaD
Estriol—SLCO1A2—Metabolism—SLC2A1—ovarian cancer	2.3e-05	0.000435	CbGpPWpGaD
Estriol—ESR1—Signaling Pathways—HDAC6—ovarian cancer	2.28e-05	0.00043	CbGpPWpGaD
Estriol—SLCO1A2—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	2.26e-05	0.000426	CbGpPWpGaD
Estriol—SLCO1A2—Metabolism—CYP1B1—ovarian cancer	2.21e-05	0.000417	CbGpPWpGaD
Estriol—ABCB1—Transmembrane transport of small molecules—SLC5A5—ovarian cancer	2.18e-05	0.000412	CbGpPWpGaD
Estriol—ESR1—Integrated Pancreatic Cancer Pathway—AKT1—ovarian cancer	2.18e-05	0.000411	CbGpPWpGaD
Estriol—ABCB1—Metabolism—CYTB—ovarian cancer	2.17e-05	0.00041	CbGpPWpGaD
Estriol—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—ovarian cancer	2.17e-05	0.00041	CbGpPWpGaD
Estriol—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—ovarian cancer	2.13e-05	0.000402	CbGpPWpGaD
Estriol—ABCB1—Transmembrane transport of small molecules—SLC2A1—ovarian cancer	2.11e-05	0.000398	CbGpPWpGaD
Estriol—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—ovarian cancer	2.07e-05	0.000391	CbGpPWpGaD
Estriol—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—ovarian cancer	2.05e-05	0.000387	CbGpPWpGaD
Estriol—ESR1—Gene Expression—PPP2R1A—ovarian cancer	2.04e-05	0.000385	CbGpPWpGaD
Estriol—ESR1—Signaling Pathways—YAP1—ovarian cancer	2.01e-05	0.00038	CbGpPWpGaD
Estriol—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—ovarian cancer	2e-05	0.000378	CbGpPWpGaD
Estriol—ESR1—Signaling Pathways—XIAP—ovarian cancer	1.97e-05	0.000372	CbGpPWpGaD
Estriol—SLCO1A2—Metabolism—PPP2R1A—ovarian cancer	1.96e-05	0.00037	CbGpPWpGaD
Estriol—SLCO1A2—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	1.95e-05	0.000368	CbGpPWpGaD
Estriol—ESR1—Signaling Pathways—SMARCA4—ovarian cancer	1.92e-05	0.000363	CbGpPWpGaD
Estriol—ABCB1—Metabolism—PPP1CC—ovarian cancer	1.9e-05	0.000359	CbGpPWpGaD
Estriol—ABCB1—Metabolism—BRIP1—ovarian cancer	1.9e-05	0.000359	CbGpPWpGaD
Estriol—ESR1—Signaling Pathways—EREG—ovarian cancer	1.88e-05	0.000354	CbGpPWpGaD
Estriol—SLCO1A2—Metabolism—ABCB1—ovarian cancer	1.82e-05	0.000344	CbGpPWpGaD
Estriol—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—ovarian cancer	1.81e-05	0.000341	CbGpPWpGaD
Estriol—SLCO1A2—Metabolism—TYMS—ovarian cancer	1.79e-05	0.000337	CbGpPWpGaD
Estriol—ESR1—Signaling Pathways—PGR—ovarian cancer	1.76e-05	0.000332	CbGpPWpGaD
Estriol—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—ovarian cancer	1.71e-05	0.000323	CbGpPWpGaD
Estriol—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—ovarian cancer	1.66e-05	0.000314	CbGpPWpGaD
Estriol—ESR1—Signaling Pathways—PARP1—ovarian cancer	1.63e-05	0.000309	CbGpPWpGaD
Estriol—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—ovarian cancer	1.63e-05	0.000307	CbGpPWpGaD
Estriol—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—ovarian cancer	1.63e-05	0.000307	CbGpPWpGaD
Estriol—ESR1—Generic Transcription Pathway—MYC—ovarian cancer	1.56e-05	0.000295	CbGpPWpGaD
Estriol—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—ovarian cancer	1.54e-05	0.00029	CbGpPWpGaD
Estriol—ESR2—Gene Expression—MAPK3—ovarian cancer	1.53e-05	0.000289	CbGpPWpGaD
Estriol—ESR2—Gene Expression—MYC—ovarian cancer	1.49e-05	0.000281	CbGpPWpGaD
Estriol—SLCO1A2—Metabolism—CAV1—ovarian cancer	1.44e-05	0.000272	CbGpPWpGaD
Estriol—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—ovarian cancer	1.41e-05	0.000266	CbGpPWpGaD
Estriol—SLCO1A2—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	1.38e-05	0.00026	CbGpPWpGaD
Estriol—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—ovarian cancer	1.36e-05	0.000258	CbGpPWpGaD
Estriol—ESR1—Signaling Pathways—PPP2R1A—ovarian cancer	1.33e-05	0.00025	CbGpPWpGaD
Estriol—SLCO1A2—Metabolism—PIK3CG—ovarian cancer	1.31e-05	0.000248	CbGpPWpGaD
Estriol—ABCB1—Metabolism—YAP1—ovarian cancer	1.27e-05	0.000241	CbGpPWpGaD
Estriol—SLCO1A2—Metabolism—PIK3CD—ovarian cancer	1.15e-05	0.000218	CbGpPWpGaD
Estriol—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—ovarian cancer	1.15e-05	0.000218	CbGpPWpGaD
Estriol—ESR1—Signaling Pathways—TERT—ovarian cancer	1.05e-05	0.000199	CbGpPWpGaD
Estriol—ABCB1—Metabolism—FASN—ovarian cancer	1.04e-05	0.000196	CbGpPWpGaD
Estriol—ESR2—Gene Expression—AKT1—ovarian cancer	1.03e-05	0.000195	CbGpPWpGaD
Estriol—ABCB1—Metabolism—SLC5A5—ovarian cancer	1.02e-05	0.000193	CbGpPWpGaD
Estriol—SLCO1A2—Metabolism—PIK3CB—ovarian cancer	1.01e-05	0.00019	CbGpPWpGaD
Estriol—ABCB1—Metabolism—SLC2A1—ovarian cancer	9.87e-06	0.000186	CbGpPWpGaD
Estriol—ESR1—Signaling Pathways—CAV1—ovarian cancer	9.74e-06	0.000184	CbGpPWpGaD
Estriol—ABCB1—Metabolism—CYP1B1—ovarian cancer	9.46e-06	0.000179	CbGpPWpGaD
Estriol—ESR1—Signaling Pathways—IL6ST—ovarian cancer	9.24e-06	0.000174	CbGpPWpGaD
Estriol—ESR1—Signaling Pathways—PIK3CG—ovarian cancer	8.87e-06	0.000168	CbGpPWpGaD
Estriol—ESR1—Signaling Pathways—APC—ovarian cancer	8.87e-06	0.000168	CbGpPWpGaD
Estriol—SLCO1A2—Metabolism—PTEN—ovarian cancer	8.68e-06	0.000164	CbGpPWpGaD
Estriol—ABCB1—Metabolism—PPP2R1A—ovarian cancer	8.39e-06	0.000158	CbGpPWpGaD
Estriol—ESR1—Signaling Pathways—PIK3CD—ovarian cancer	7.8e-06	0.000147	CbGpPWpGaD
Estriol—ESR1—Gene Expression—MAPK3—ovarian cancer	7.72e-06	0.000146	CbGpPWpGaD
Estriol—ABCB1—Metabolism—TYMS—ovarian cancer	7.65e-06	0.000144	CbGpPWpGaD
Estriol—ESR1—Gene Expression—MYC—ovarian cancer	7.51e-06	0.000142	CbGpPWpGaD
Estriol—ESR1—Signaling Pathways—ERBB2—ovarian cancer	6.89e-06	0.00013	CbGpPWpGaD
Estriol—ESR1—Signaling Pathways—PIK3CB—ovarian cancer	6.8e-06	0.000128	CbGpPWpGaD
Estriol—ESR1—Signaling Pathways—MTOR—ovarian cancer	6.8e-06	0.000128	CbGpPWpGaD
Estriol—ESR1—Signaling Pathways—CXCL8—ovarian cancer	6.53e-06	0.000123	CbGpPWpGaD
Estriol—ESR1—Signaling Pathways—CDKN1B—ovarian cancer	6.38e-06	0.00012	CbGpPWpGaD
Estriol—ESR1—Signaling Pathways—CASP3—ovarian cancer	6.25e-06	0.000118	CbGpPWpGaD
Estriol—ESR1—Signaling Pathways—IL2—ovarian cancer	6.24e-06	0.000118	CbGpPWpGaD
Estriol—ABCB1—Metabolism—CAV1—ovarian cancer	6.16e-06	0.000116	CbGpPWpGaD
Estriol—SLCO1A2—Metabolism—PIK3CA—ovarian cancer	6.13e-06	0.000116	CbGpPWpGaD
Estriol—ESR1—Signaling Pathways—CCND1—ovarian cancer	6.09e-06	0.000115	CbGpPWpGaD
Estriol—ESR1—Signaling Pathways—CTNNB1—ovarian cancer	6.03e-06	0.000114	CbGpPWpGaD
Estriol—ESR1—Signaling Pathways—MMP9—ovarian cancer	5.91e-06	0.000112	CbGpPWpGaD
Estriol—ESR1—Signaling Pathways—PTEN—ovarian cancer	5.88e-06	0.000111	CbGpPWpGaD
Estriol—ABCB1—Metabolism—PIK3CG—ovarian cancer	5.62e-06	0.000106	CbGpPWpGaD
Estriol—ESR1—Signaling Pathways—VEGFA—ovarian cancer	5.31e-06	0.0001	CbGpPWpGaD
Estriol—ESR1—Signaling Pathways—STAT3—ovarian cancer	5.26e-06	9.92e-05	CbGpPWpGaD
Estriol—ESR1—Signaling Pathways—NRAS—ovarian cancer	5.24e-06	9.9e-05	CbGpPWpGaD
Estriol—ESR1—Gene Expression—AKT1—ovarian cancer	5.21e-06	9.83e-05	CbGpPWpGaD
Estriol—ESR1—Signaling Pathways—MAPK3—ovarian cancer	5.02e-06	9.48e-05	CbGpPWpGaD
Estriol—SLCO1A2—Metabolism—AKT1—ovarian cancer	5.01e-06	9.45e-05	CbGpPWpGaD
Estriol—ABCB1—Metabolism—PIK3CD—ovarian cancer	4.94e-06	9.32e-05	CbGpPWpGaD
Estriol—ESR1—Signaling Pathways—MYC—ovarian cancer	4.88e-06	9.22e-05	CbGpPWpGaD
Estriol—ESR1—Signaling Pathways—MAPK1—ovarian cancer	4.78e-06	9.02e-05	CbGpPWpGaD
Estriol—ESR1—Signaling Pathways—EGFR—ovarian cancer	4.78e-06	9.02e-05	CbGpPWpGaD
Estriol—ESR1—Signaling Pathways—KRAS—ovarian cancer	4.51e-06	8.52e-05	CbGpPWpGaD
Estriol—ABCB1—Metabolism—PIK3CB—ovarian cancer	4.3e-06	8.12e-05	CbGpPWpGaD
Estriol—ESR1—Signaling Pathways—PIK3CA—ovarian cancer	4.15e-06	7.83e-05	CbGpPWpGaD
Estriol—ESR1—Signaling Pathways—TP53—ovarian cancer	4.01e-06	7.57e-05	CbGpPWpGaD
Estriol—ESR1—Signaling Pathways—HRAS—ovarian cancer	3.84e-06	7.24e-05	CbGpPWpGaD
Estriol—ABCB1—Metabolism—PTEN—ovarian cancer	3.72e-06	7.02e-05	CbGpPWpGaD
Estriol—ESR1—Signaling Pathways—IL6—ovarian cancer	3.67e-06	6.93e-05	CbGpPWpGaD
Estriol—ESR1—Signaling Pathways—AKT1—ovarian cancer	3.39e-06	6.39e-05	CbGpPWpGaD
Estriol—ABCB1—Metabolism—PIK3CA—ovarian cancer	2.62e-06	4.95e-05	CbGpPWpGaD
Estriol—ABCB1—Metabolism—AKT1—ovarian cancer	2.14e-06	4.05e-05	CbGpPWpGaD
